| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NOVAVAX INC | Director | Common Stock | 54,340 | $336,364 | $6.19 | 12 Jun 2025 | Direct |
| MAXCYTE, INC. | Director | Common Stock | 230,577 | $320,040 | $1.39 | 13 Aug 2025 | Direct |
| NOVAVAX INC | Director | Stock Option (Right to Buy) | 28,326 | $181,852 | $6.42 | 20 Jun 2025 | Direct |
| NOVAVAX INC | Director | Restricted Stock Units | 18,884 | $144,838 | $13.90 | 20 Jun 2025 | Direct |
| MAXCYTE, INC. | Director | Stock Option (right to buy) | 50,790 | 18 Jun 2025 | Direct | ||
| Aldeyra Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 1,689 | 10 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MXCT | MAXCYTE, INC. | 13 Aug 2025 | 1 | +$111,040 | 4 | Director | 13 Aug 2025, 19:46 |
| NVAX | NOVAVAX INC | 20 Jun 2025 | 2 | +$181,853 | 4 | Director | 24 Jun 2025, 18:37 |
| MXCT | MAXCYTE, INC. | 18 Jun 2025 | 2 | $0 | 4 | Director | 23 Jun 2025, 18:39 |
| NVAX | NOVAVAX INC | 12 Jun 2025 | 2 | $0 | 4 | Director | 13 Jun 2025, 21:36 |
| ALDX | Aldeyra Therapeutics, Inc. | 10 Jun 2025 | 3 | $0 | 4 | Director | 12 Jun 2025, 16:27 |
| NVAX | NOVAVAX INC | 12 Jun 2024 | 4 | +$247,892 | 4 | Director | 14 Jun 2024, 16:10 |
| MXCT | MAXCYTE, INC. | 11 Jun 2024 | 2 | $0 | 4 | Director | 13 Jun 2024, 17:39 |
| ALDX | Aldeyra Therapeutics, Inc. | 04 Jun 2024 | 3 | $0 | 4 | Director | 06 Jun 2024, 16:15 |
| ALDX | Aldeyra Therapeutics, Inc. | 30 Jun 2023 | 3 | $0 | 4 | Director | 05 Jul 2023, 17:32 |
| MXCT | MAXCYTE, INC. | 22 Jun 2023 | 1 | $0 | 4 | Director | 23 Jun 2023, 17:34 |
| NVAX | NOVAVAX INC | 10 Jun 2023 | 4 | $0 | 4 | Director | 13 Jun 2023, 16:44 |
| MXCT | MAXCYTE, INC. | 29 Mar 2023 | 1 | +$345,480 | 4 | Director | 30 Mar 2023, 09:11 |
| MXCT | MAXCYTE, INC. | 29 Jun 2022 | 1 | $0 | 4 | Director | 08 Jul 2022, 16:05 |
| NVAX | NOVAVAX INC | 17 Jun 2022 | 2 | $0 | 4 | Director | 21 Jun 2022, 20:46 |
| NVAX | NOVAVAX INC | 10 Jun 2022 | 2 | $0 | 4 | Director | 14 Jun 2022, 17:07 |
| ALDX | Aldeyra Therapeutics, Inc. | 07 Jun 2022 | 3 | $0 | 4 | Director | 09 Jun 2022, 17:06 |
| NVAX | NOVAVAX INC | 13 Dec 2021 | 2 | +$38,400 | 4 | Director | 15 Dec 2021, 16:22 |
| MXCT | MAXCYTE, INC. | 22 Nov 2021 | 1 | +$222,400 | 4 | Director | 23 Nov 2021, 06:46 |
| MXCT | MAXCYTE, INC. | 09 Aug 2021 | 1 | $0 | 4 | Director | 11 Aug 2021, 17:13 |
| MXCT | MAXCYTE, INC. | 29 Jul 2021 | 0 | $0 | 3 | Director | 29 Jul 2021, 18:36 |
| NVAX | NOVAVAX INC | 25 Jun 2021 | 2 | $0 | 4 | Director | 29 Jun 2021, 17:13 |
| NVAX | NOVAVAX INC | 17 Jun 2021 | 2 | $0 | 4 | Director | 22 Jun 2021, 17:16 |
| ALDX | Aldeyra Therapeutics, Inc. | 08 Jun 2021 | 3 | $0 | 4 | Director | 10 Jun 2021, 17:46 |